Tuberculosis - Clinical trials 

Clinical trials for Tuberculosis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Tuberculosis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Tuberculosis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Tuberculosis
Title Recruitment status Location
A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A Recruiting United Kingdom
Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route Recruiting United Kingdom
A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6) Not recruiting United Kingdom
T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals Not recruiting United Kingdom
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously Not recruiting United Kingdom
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG Not recruiting United Kingdom
A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG Not recruiting United Kingdom
T-Cell Turnover Following Vaccination With MVA85A Not recruiting United Kingdom
A phase I study evaluating the safety and immunogenicity of a new tuberculosis (TB) vaccine, MVA85A, in healthy volunteers who are infected with human immunodeficiency virus (HIV) Not recruiting United Kingdom
A phase I study to compare the safety and immunogenicity of candidate tuberculosis (TB) vaccine MVA85A administered by the intramuscular route and the intradermal route Not recruiting United Kingdom